Log in

NASDAQ:DYNTDynatronics Stock Price, Forecast & News

$0.80
-0.04 (-4.23 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.79
Now: $0.80
$0.87
50-Day Range
$0.83
MA: $0.90
$1.05
52-Week Range
$0.63
Now: $0.80
$3.70
Volume359,841 shs
Average Volume1.13 million shs
Market Capitalization$10.97 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.18
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.
Read More
Dynatronics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.38 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DYNT
CUSIPN/A
Phone801-568-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$62.56 million
Cash Flow$0.06 per share
Book Value$1.08 per share

Profitability

Net Income$-920,000.00

Miscellaneous

Employees323
Market Cap$10.97 million
Next Earnings Date9/23/2020 (Estimated)
OptionableNot Optionable
$0.80
-0.04 (-4.23 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DYNT News and Ratings via Email

Sign-up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Dynatronics (NASDAQ:DYNT) Frequently Asked Questions

How has Dynatronics' stock been impacted by Coronavirus?

Dynatronics' stock was trading at $1.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DYNT shares have decreased by 44.0% and is now trading at $0.7951.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Dynatronics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Dynatronics
.

When is Dynatronics' next earnings date?

Dynatronics is scheduled to release its next quarterly earnings announcement on Wednesday, September 23rd 2020.
View our earnings forecast for Dynatronics
.

How were Dynatronics' earnings last quarter?

Dynatronics Co. (NASDAQ:DYNT) released its quarterly earnings data on Thursday, May, 14th. The medical equipment provider reported ($0.13) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.09. The medical equipment provider had revenue of $13.71 million for the quarter. Dynatronics had a negative return on equity of 13.41% and a negative net margin of 2.24%.
View Dynatronics' earnings history
.

What guidance has Dynatronics issued on next quarter's earnings?

Dynatronics issued an update on its fourth quarter 2020 Pre-Market earnings guidance on Wednesday, July, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $7.9-8.2 million, compared to the consensus revenue estimate of $7.6 million.

What price target have analysts set for DYNT?

3 brokers have issued 12 month price objectives for Dynatronics' shares. Their forecasts range from $1.30 to $2.00. On average, they expect Dynatronics' stock price to reach $1.58 in the next year. This suggests a possible upside of 99.1% from the stock's current price.
View analysts' price targets for Dynatronics
.

Has Dynatronics been receiving favorable news coverage?

News coverage about DYNT stock has been trending neutral on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dynatronics earned a daily sentiment score of 0.1 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Dynatronics
.

Are investors shorting Dynatronics?

Dynatronics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 291,700 shares, an increase of 117.7% from the June 15th total of 134,000 shares. Based on an average daily volume of 1,630,000 shares, the days-to-cover ratio is presently 0.2 days.
View Dynatronics' Short Interest
.

Who are some of Dynatronics' key competitors?

What other stocks do shareholders of Dynatronics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dynatronics investors own include Biocept (BIOC), CHF Solutions (CHFS), American Airlines Group (AAL), Allena Pharmaceuticals (ALNA), Amplify Energy (AMPY), Amplify Energy (AMPY), Avinger (AVGR), Gevo (GEVO), Heat Biologics (HTBX) and Inpixon (INPX).

Who are Dynatronics' key executives?

Dynatronics' management team includes the following people:
  • Dr. Christopher Richard Von Jako, CEO & Director (Age 49)
  • Mr. David A. Wirthlin, CFO & Sec. (Age 58)
  • Mr. Terry M. Atkinson CPA, CGMA, Director of Accounting (Age 66)
  • Mr. Daryl Connell, Chief Information Officer (Age 47)
  • Mr. Skyler Black, Corp. Controller (Age 36)

What is Dynatronics' stock symbol?

Dynatronics trades on the NASDAQ under the ticker symbol "DYNT."

How do I buy shares of Dynatronics?

Shares of DYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dynatronics' stock price today?

One share of DYNT stock can currently be purchased for approximately $0.80.

How big of a company is Dynatronics?

Dynatronics has a market capitalization of $10.97 million and generates $62.56 million in revenue each year. The medical equipment provider earns $-920,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. Dynatronics employs 323 workers across the globe.

What is Dynatronics' official website?

The official website for Dynatronics is www.dynatronics.com.

How can I contact Dynatronics?

Dynatronics' mailing address is 1200 TRAPP ROAD, EAGAN MN, 55121. The medical equipment provider can be reached via phone at 801-568-7000 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.